Founded Year

2012

Stage

Debt - IV | Alive

Total Raised

$9.82M

Last Raised

$310K | 1 yr ago

Mosaic Score

+20 points in the past 30 days

What is a Mosaic Score?
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

About Rimidi

Rimidi is a cloud-based software platform that enables personalized management of chronic cardiometabolic conditions across populations, with specific views for diabetes, heart failure, fatty liver, and cardiovascular disease. Created by doctors, Rimidi avoids the disconnect in connected care by combining patient-generated health data with EHR systems to drive patient-specific clinical insights and actions. The net effect is a better health system with optimized clinical workflows that enable better decisions, better relationships, better outcomes, and ultimately a better healthcare system.

Rimidi Headquarter Location

75 5th Street NW Suite 2260

Atlanta, Georgia, 30308,

United States

404-317-4400

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Rimidi's Products & Differentiation

See Rimidi's products and how their products differentiate from alternatives and competitors

  • Cardiometabolic Platform

    Rimidi’s cardiometabolic platform supports disease management of some of the most prevalent and costly chronic conditions. The platform provides access to the tools required to manage multiple disease states – Diabetes, Cardiovascular Disease/Hypertension, Heart Failure, Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH), and Obesity. The platform consolidates relevant clinical data from the EMR for each disease state with patient-generated health data from connected devices or surveys, and layers on clinical decision support that can be mapped against national or practice guidelines. Our cardiometabolic snapshot allows clinicians to quickly assess patient status for each comorbid disease state -- are screenings up to date? Are key metrics well-controlled?

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

Expert Collections containing Rimidi

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Rimidi is included in 6 Expert Collections, including Digital Health.

D

Digital Health

12,922 items

Startups recreating how healthcare is delivered

C

Conference Exhibitors

5,302 items

D

Diabetes

1,750 items

T

Telehealth

2,800 items

Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.

H

Health IT

3,463 items

This collection includes public and private companies, as well as startups, that market software solutions to healthcare provider organizations.

H

Health Monitoring & Diagnostics

838 items

Companies offering products that help assess patients’ state of health and well-being from a distance. Tagged as #RemoteMonitoring&Diagnostics

Rimidi Patents

Rimidi has filed 6 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/26/2012

7/1/2014

Diabetes, Insulin therapies, Blood tests, Self care, Nutrition

Grant

Application Date

7/26/2012

Grant Date

7/1/2014

Title

Related Topics

Diabetes, Insulin therapies, Blood tests, Self care, Nutrition

Status

Grant

Latest Rimidi News

Digital health execs on health system reluctance: ‘Partnering with people isn’t a bad thing’

May 20, 2022

Left to right: Dr. Amit Phull, vice president of strategy at Doximity and an emergency physician at Northwestern Medicine; Dr. Rushika Fernadopulle, chief innovation officer at One Medical; Linda Finkel, CEO of Avia; Dr. Lucienne Ide, CEO of Rimidi; James Nicholls, partner at Fitzroy Health. Veteran executives of digital health companies have heard it all when it comes to health system reluctance in adopting new technology. “We often get a litany of reasons why it’s not possible,” said Dr. Rushika Fernadopulle, chief innovation officer at One Medical. “First they ask, ‘Why should I be doing this?’ Let’s assume they get over that part. Then they say, ‘We already do this,’ which is usually not true. Then my favorite is, ‘We couldn’t do this if we wanted to.’” Fernadopulle said there is a certain level of hubris at health systems and payers regarding their unwillingness to disrupt their own businesses and partner with digital health companies. The organizations tend to think they can do it all, although he added that attitude is changing. “They’re starting to realize that partnering with people isn’t a bad thing and maybe that’s the path forward,” he said earlier this week at Modern Healthcare’s Transformation Summit, Austin, Texas. Fernadopulle founded Iora Health, a company that offers tech-enabled primary care services to Medicare patients by partnering with health systems and payers. It was sold to One Medical , another tech-enabled primary care company, for $2.1 billion in June 2021. He was joined on the panel by James Nicholls, partner at Fitzroy Health; Linda Finkel, CEO of Avia; Dr. Lucienne Ide, CEO of Rimidi; and Dr. Amit Phull, vice president of strategy at Doximity and an emergency physician at Northwestern Medicine. While some executives at health systems are eager to change , digital health companies perceive a culture clash between the two sides holding back widespread transformation. The very word ‘disruption’ is likely to make health systems cringe, Nicholls said. “You have to acknowledge that while disruption is an exciting and provocative word in Silicon Valley, that’s not the reaction you get in healthcare,” Nicholls said. “Changing the word is a sensible idea because the psychology of it doesn’t fit neatly with healthcare.” Nicholls said there is a huge disconnect between a health system’s C-suite and board, which talk about the need to disrupt from within, and the people who run an organization on a daily basis. Change management remains one of the biggest barriers to transformation, he said. Panelists said C-suite executives often participate in “innovation theater,” meaning they talk about innovation and disruption, but then take the safe bet and don’t put their words into action. A common excuse that health systems tend to use when avoiding digital health adoption is centered on Epic, the prominent electronic health record system. “My favorite saying [from health systems] is, ‘We’re an Epic shop so we’re going to have Epic do everything,’” Ide said. “For years, the dialogue was, ‘Epic is going to build that.’ It’s frustrating because it’s an excuse in a lot of ways. And I’m not trying to diminish that because it’s a huge enterprise investment and they should maximize it, but that’s the safe bet.” Whether they want to or not, Fernadopulle said health system and insurance executives have no choice but to disrupt themselves from within. “Healthcare in its roots is a consumer business,” Fernadopulle said. “Patients and consumers are free to vote with their feet. If someone builds a better mouse trap, they’re going to walk.”

Rimidi Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Rimidi Rank

  • When was Rimidi founded?

    Rimidi was founded in 2012.

  • Where is Rimidi's headquarters?

    Rimidi's headquarters is located at 75 5th Street NW, Atlanta.

  • What is Rimidi's latest funding round?

    Rimidi's latest funding round is Debt - IV.

  • How much did Rimidi raise?

    Rimidi raised a total of $9.82M.

  • Who are Rimidi's competitors?

    Competitors of Rimidi include Vivify Health and 2 more.

  • What products does Rimidi offer?

    Rimidi's products include Cardiometabolic Platform and 4 more.

  • Who are Rimidi's customers?

    Customers of Rimidi include Desert Oasis Healthcare, Emory Healthcare, Boston Medical Center, Northeast Valley Health Corporation and Leon Medical Centers.

You May Also Like

Babyscripts Logo
Babyscripts

Babyscripts is a doctor-delivered, digital health tool for prenatal care, enhancing the doctor/patient relationship outside of the clinic's walls during routine, low-risk pregnancy care and providing remote monitoring to better identify high-risk pregnancies.

Aventyn Logo
Aventyn

Aventyn is a digital therapeutics company. The company delivers clinical evidenced telehealth solutions for personalized remote chronic care, medical imaging, intelligent predictive analytics, and risk assessment. It is based in Carlsbad, California.

T
Tendo Systems

Tendo Systems develops a unified software platform for healthcare.

Monitored Therapeutics Logo
Monitored Therapeutics

Monitored Therapeutics is a Respiratory Telehealthcare Company focused on COPD, Asthma, Lung Transplant, and Cystic Fibrosis with four proprietary products - GoSpiro® Home Spirometer, GoHome™ Patient Health Monitor, GoClinic, GoECG, and the MTI CarePortal™. The company extends Access to Care to the patient and provider through a standardized platform, increasing Patient Engagement, Drug Adherence, and Quality of Life, while decreasing overall healthcare costs by keeping patients in their homes and out of the hospital.

Qventus Logo
Qventus

Qventus uses a hospital's data along with proprietary external data signals to help managers proactively manage day-to-day operations. Qventus' algorithms analyze hospital data along with important operational and clinical metrics, allowing hospital staff to both monitor operational performance and automatically diagnose operational issues in real-time. In addition, Qventus' machine-learning-based forecasting techniques enable hospitals to predict patient volumes and optimally allocate resources – such as staff, beds, and rooms – to meet this demand. These insights are delivered to staff in the workflows with which they are already accustomed. Qventus was founded in 2012 and is based in Mountain View, CA.

CliniServe Logo
CliniServe

Cliniserve is a nursing task management and communication system that helps reduce workload on nurses in stationary care settings like hospitals and nursing homes. It simplifies and automates processes and helps solve the global personnel shortage in nursing.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.